|
Real-time Estimate
Cboe BZX
18:54:19 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.690 USD | -0.21% |
|
+2.97% | -7.62% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 06-01 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.21% | +2.97% | +5.09% | -10.10% | -7.62% | +59.02% | -20.20% | -19.17% | - | 1.33B | |
| +2.07% | +10.05% | +31.65% | +47.13% | +79.09% | +77.41% | +106.53% | +16.62% | - | 70.1B | |
| -0.87% | +0.08% | -0.68% | +9.78% | +5.25% | +36.96% | +65.04% | +182.97% | +5,378.58% | 54.93B | |
| -3.73% | -3.79% | +16.85% | +8.09% | -26.72% | +3.79% | +471.88% | +441.30% | +916.99% | 28.89B | |
| +0.04% | +12.56% | +20.44% | +35.67% | +45.42% | +54.67% | +5.47% | -61.93% | - | 23.9B | |
| -0.12% | +1.69% | +2.95% | +0.54% | -2.59% | -17.78% | -13.69% | -75.42% | - | 23.3B | |
| +0.35% | +8.24% | +12.45% | +125.44% | +241.04% | +252.94% | +466.50% | +1,800.42% | +864.12% | 18.41B | |
| -0.59% | +7.88% | +6.38% | +20.25% | -0.10% | +40.87% | -20.12% | -31.36% | +78.73% | 18.77B | |
| -0.57% | +6.85% | +1.74% | +14.04% | +33.99% | +30.20% | +580.70% | - | - | 16.1B | |
| +1.00% | -2.53% | -9.21% | -0.80% | +16.08% | +32.19% | +136.54% | +178.34% | +372.86% | 12.48B | |
| -0.40% | +0.87% | +16.82% | +11.16% | +30.40% | +333.09% | +194.57% | +43.05% | +1,314.62% | 12.32B | |
| -3.68% | +2.17% | -1.80% | +0.50% | -10.46% | +39.62% | +200.65% | +514.47% | +6,309.83% | 12.39B | |
| -2.65% | +8.38% | -4.08% | -21.90% | -16.09% | -45.39% | +641.16% | +85.29% | +117.41% | 12.05B | |
| +1.47% | +8.48% | +6.53% | -20.31% | -8.32% | -33.80% | +208.79% | +135.99% | - | 11.98B | |
| -1.80% | -8.28% | -9.25% | -3.35% | +17.45% | +102.36% | +132.49% | +132.13% | +514.24% | 10.52B | |
| +0.24% | -0.06% | -1.90% | -13.07% | +14.58% | +25.19% | +119.41% | -26.34% | - | 8.99B | |
| -1.57% | -0.77% | +9.49% | +34.48% | +213.26% | +489.80% | +771.55% | -31.92% | -12.47% | 9.18B | |
| +0.05% | +0.70% | +1.00% | +125.47% | +81.54% | +180.84% | +401.81% | +279.63% | - | 8.96B | |
| +0.27% | +1.77% | +5.09% | +10.47% | +29.89% | +89.95% | +30.28% | +130.23% | - | 8.88B | |
| -1.10% | +4.58% | -1.73% | -6.07% | +286.62% | +171.45% | +313.78% | -31.96% | - | 8.2B | |
| Average | -0.59% | +5.28% | +5.39% | +18.37% | +51.14% | +96.17% | +239.66% | +192.75% | +1,585.49% | 18.58B | |
| Weighted average by Cap. | -0.31% | +6.71% | +10.01% | +23.67% | +45.28% | +75.65% | +201.31% | +194.90% | +2,343.21% |
- Stock Market
- Stocks
- IMTX Stock
- Sector Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
